Position in RYTM
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$7,979,410
-$964,210 QoQ
Shares Held
91,749
+9.8% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 76.39429312581063.ToString("F0")%
Shared 0.ToString("F0")%
None 23.605706874189362.ToString("F0")%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AXIOM INVESTORS LLC /DE holds $88,046,456 across 7 Biotechnology names. RYTM ranks #5 (9.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
239,447 | $39,154,373 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
199,988 | $14,851,108 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
56,529 | $9,554,531 | |
| 4 | PTGX |
Protagonist Therapeutics, Inc
|
85,475 | $9,009,065 | |
| 5 | RYTM |
Rhythm Pharmaceuticals, Inc.
This page
|
91,749 | $7,979,410 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
99,568 | $5,789,879 | |
| 7 | VOR |
Vor Biopharma Inc.
|
95,745 | $1,708,090 |
All Filings in RYTM
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,979,410 | 91,749 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $8,943,620 | 83,554 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $8,385,300 | 83,031 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,314,947 | 52,460 | Shares | Sole | 2025-08-07 | |
| No filing history on record for this holder in this stock. | ||||||